Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Cancer Research|May 7, 2009
Loss of the SMRT/NCoR2 corepressor correlates with JAG2 overexpression in multiple myelomaPushpankur Ghoshal, Alain J Nganga, Joseph Moran-Giuati, et al.
Blood Advances|May 19, 2020
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responsesAlak Manna, Timothy Kellett, Sonikpreet Aulakh, et al.
Annals of Hematology|December 9, 2017
Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignanciesAmanda J Shreders, Shehzad K Niazi, David O Hodge, et al.
Frontiers in Immunology|March 14, 2022
Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in MacrophagesClaudia C S Chini, Thais R Peclat, Lilian S Gomez, et al.
Blood|June 27, 2007
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelomaDeborah J Kuhn, Qing Chen, Peter M Voorhees, et al.
British Journal of Haematology|January 29, 2024
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemiaRicardo D Parrondo, Navnita Dutta, Betsy R LaPlant, et al.
British Journal of Haematology|August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cellsAneel Paulus, Alak Manna, Sharoon Akhtar, et al.
Cancer|May 2, 2015
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomesSameer A Parikh, Jose F Leis, Kari G Chaffee, et al.
The Lancet. Haematology|August 30, 2016
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trialPaolo Strati, Mark Lanasa, Timothy G Call, et al.
Anti-Cancer Drugs|April 17, 2023
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myelomaMuhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, et al.
Pageof 9